Регистрация | Вход в службу | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

psique parkinsons [69 articles]

Recent papers added to psique library classified by the tag parkinsons. You can also see everyone's parkinsons.
  • Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
    Movement disorders : official journal of the Movement Disorder Society, Vol. 20, No. 9. (September 2005), pp. 1191-1194.
  • The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
    Frontiers in bioscience : a journal and virtual library, Vol. 13 (2008), pp. 718-736.
    by JJ Shacka, KA Roth, J Zhang
  • Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
    Lancet neurology, Vol. 7, No. 1. (January 2008), pp. 97-109.
    by AH Schapira
  • Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.
    Neuro-Signals, Vol. 16, No. 1. (2008), pp. 24-34.
    posted to parkinsons dementia 2008 by psique on 2008-06-12 19:14:19 as **
  • Mutations in LRRK2 as a cause of Parkinson's disease.
    Neuro-Signals, Vol. 16, No. 1. (2008), pp. 99-105.
  • Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
    Experimental neurology, Vol. 209, No. 1. (January 2008), pp. 12-21.
    by GM Halliday, H McCann
  • In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?
    Experimental neurology, Vol. 209, No. 1. (January 2008), pp. 22-27.
    by MF Chesselet
  • Programmed cell death and new discoveries in the genetics of parkinsonism
    Journal of Neurochemistry, Vol. 104, No. 4. (February 2008), pp. 875-890.
  • Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    JAMA : the journal of the American Medical Association, Vol. 296, No. 6. (9 August 2006), pp. 661-670.
  • alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Annals of neurology, Vol. 56, No. 4. (October 2004), pp. 591-595.
  • Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 2. (18 January 2000), pp. 571-576.
    by KA Conway, SJ Lee, JC Rochet, TT Ding, RE Williamson, PT Lansbury
    posted to synuclein parkinsons 2000 by psique on 2008-06-11 21:06:56 as **
  • Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.
    Science (New York, N.Y.), Vol. 287, No. 5456. (18 February 2000), pp. 1265-1269.
  • Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 24, No. 42. (20 October 2004), pp. 9434-9440.
  • Sensitivity to Oxidative Stress in DJ-1-Deficient Dopamine Neurons: An ES- Derived Cell Model of Primary Parkinsonism
    PLoS Biology, Vol. 2, No. 11. (1 November 2004), e327.
    by Cecile Martinat, Shoshana Shendelman, Alan Jonason, Thomas Leete, Flint M Beal, Lichuan Yang, Thomas Floss, Asa Abeliovich
  • DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation
    PLoS Biology, Vol. 2, No. 11. (1 November 2004), e362.
    by Shoshana Shendelman, Alan Jonason, Cecile Martinat, Thomas Leete, Asa Abeliovich
  • Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease
    European Journal of Neuroscience, Vol. 27, No. 8. (April 2008), pp. 2133-2146.
    by Smith, K Lori, Jadavji, M Nafisa, Colwell, L Keri, Katrina Perehudoff, , Metz, A Gerlinde
  • The [alpha]-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease
    Experimental Neurology, Vol. In Press, Corrected Proof
    by Patrick L Mcgeer, Edith G Mcgeer
  • Altered vesicular dopamine storage in Parkinson's disease: a premature demise
    Trends in Neurosciences, Vol. 31, No. 6. (June 2008), pp. 303-308.
    by Michael W Caudle, Rebecca E Colebrooke, Piers C Emson, Gary W Miller
  • Parkinson's disease and pesticides: a toxicological perspective
    Trends in Pharmacological Sciences, Vol. 29, No. 6. (June 2008), pp. 322-329.
    by Jaime M Hatcher, Kurt D Pennell, Gary W Miller
  • Alpha-Synuclein and Parkinson's Disease
    (August 2001)
  • Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Current topics in developmental biology, Vol. 60 (2004), pp. 17-54.
    by EH Norris, BI Giasson, VM Lee
  • The cell biology of α-synuclein
    NeuroMolecular Medicine, Vol. 1, No. 2. (4 April 2002), pp. 95-109.
    by Nelson Cole, Diane Murphy
  • Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
    Human Molecular Genetics (April 2001), pp. 919-926.
    by CA Ross, Y Tanaka, S Engelender, S Igarashi, RK Rao, T Wanner, RE Tanzi, A Sawa, Dawson, TM Dawson
  • Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease
    Annals of Neurology, Vol. 47, No. 2. (26 April 2001), pp. 201-210.
  • Parkinson Disease
    Encyclopedia of Life Sciences (2001)
    posted to parkinsons 2001 by psique on 2008-06-03 18:59:02 as read
  • Parkinson Disease
    Encyclopedia of Life Sciences (2006)
    by N Hattori, Y Mizuno
  • Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease
    Trends in Molecular Medicine, Vol. 9, No. 3. (March 2003), pp. 126-132.
    by Ari Barzilai, Eldad Melamed
  • Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.
    Acta neuropathologica, Vol. 112, No. 3. (September 2006), pp. 237-251.
    by K Beyer
  • The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
    Trends in Neurosciences, Vol. 21, No. 6. (1 June 1998), pp. 249-254.
    by David F Clayton, Julia M George
  • The biochemistry of Parkinson's disease.
    Annu Rev Biochem, Vol. 74 (2005), pp. 29-52.
    by MR Cookson
    posted to synuclein pink1 parkinsons parkin dopamine dj-1 by psique on 2008-05-28 22:25:27 as read along with 1 person lenov
  • Neuropathological spectrum of synucleinopathies.
    Movement disorders : official journal of the Movement Disorder Society, Vol. 18 Suppl 6 (September 2003)
    by KA Jellinger
  • neuropathology of synuclein aggregates
    journal of neuroscience research, Vol. 61, No. 2. (2000), pp. 121-127.
    by JE Duda, My V Lee, JQ Trojanowski
  • Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Nature genetics, Vol. 18, No. 2. (February 1998), pp. 106-108.
  • alpha -Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
    J. Neurosci., Vol. 19, No. 14. (15 July 1999), pp. 5782-5791.
    by Natalie Ostrerova, Leonard Petrucelli, Matthew Farrer, Nitinkumar Mehta, Peter Choi, John Hardy, Benjamin Wolozin
  • Assignment of Human [alpha]-Synuclein (SNCA) and [beta]-Synuclein (SNCB) Genes to Chromosomes 4q21 and 5q35
    Genomics, Vol. 27, No. 2. (20 May 1995), pp. 379-381.
    by Maria G Spillantini, Aspasia Divane, Michel Goedert
  • Alpha-synuclein in Lewy bodies.
    Nature, Vol. 388, No. 6645. (28 August 1997), pp. 839-840.
  • Parkinson Disease : Encyclopedia of Life Sciences
    (2006)
    by N Hattori, Y Mizuno
  • Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
    Nature reviews. Neuroscience, Vol. 3, No. 12. (December 2002), pp. 932-942.
  • Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases
    Journal of Neurochemistry, Vol. 82, No. 3. (2002), pp. 449-457.
    by Philipp J Kahle, Christian Haass, Hans A Kretzschmar, Manuela Neumann
  • Polymorphisms in the receptor for GDNF (RET) are not associated with Parkinson's disease in Southern Germany
    Neurobiology of Aging, Vol. In Press, Corrected Proof
    by CB Lücking, P Lichtner, ER Kramer, C Gieger, T Illig, M Dichgans, D Berg, T Gasser
  • Characterization of Conformational and Dynamic Properties of Natively Unfolded Human and Mouse [alpha]-Synuclein Ensembles by NMR: Implication for Aggregation
    Journal of Molecular Biology, Vol. 378, No. 5. (16 May 2008), pp. 1104-1115.
    by Kuen-Phon Wu, Seho Kim, David A Fela, Jean Baum
  • Microglial responses to dopamine in a cell culture model of Parkinson's disease
    Neurobiology of Aging, Vol. In Press, Corrected Proof
    by Diego Mastroeni, Andrew Grover, Brian Leonard, Jeffrey N Joyce, Paul D Coleman, Brooke Kozik, Denise L Bellinger, Joseph Rogers
  • The aetiology of idiopathic Parkinson's disease.
    Molecular pathology : MP, Vol. 54, No. 6. (December 2001), pp. 369-380.
    by DB Ramsden, RB Parsons, SL Ho, RH Waring
  • Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
    Archives of neurology, Vol. 60, No. 7. (July 2003), pp. 975-980.
    by SA Oliveira, WK Scott, MA Nance, RL Watts, JP Hubble, WC Koller, KE Lyons, R Pahwa, MB Stern, BC Hiner, J Jankovic, WG Ondo, FH Allen, BL Scott, CG Goetz, GW Small, FL Mastaglia, JM Stajich, F Zhang, MW Booze, JA Reaves, LT Middleton, JL Haines, MA Pericak-Vance, JM Vance, ER Martin
  • Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.
    Human molecular genetics, Vol. 12, No. 20. (15 October 2003), pp. 2599-2608.
    by N Pankratz, WC Nichols, SK Uniacke, C Halter, J Murrell, A Rudolph, CW Shults, PM Conneally, T Foroud,
  • Complete genomic screen in Parkinson disease: evidence for multiple genes.
    JAMA : the journal of the American Medical Association, Vol. 286, No. 18. (14 November 2001), pp. 2239-2244.
    by WK Scott, MA Nance, RL Watts, JP Hubble, WC Koller, K Lyons, R Pahwa, MB Stern, A Colcher, BC Hiner, J Jankovic, WG Ondo, FH Allen, CG Goetz, GW Small, D Masterman, F Mastaglia, NG Laing, JM Stajich, B Slotterbeck, MW Booze, RC Ribble, E Rampersaud, SG West, RA Gibson, LT Middleton, AD Roses, JL Haines, BL Scott, JM Vance, MA Pericak-Vance
  • A common LRRK2 mutation in idiopathic Parkinson's disease
    The Lancet, Vol. 365, No. 9457. (29 January 2005), pp. 415-416.
    by William P Gilks, Patrick M Abou-Sleiman, Sonia Gandhi, Shushant Jain, Andrew Singleton, Andrew J Lees, Karen Shaw, Kailash P Bhatia, Vincenzo Bonifati, Niall P Quinn, John Lynch, Daniel G Healy, Janice L Holton, Tamas Revesz, Nicholas W Wood
  • Parkinson's disease.
    Human molecular genetics, Vol. 16 Spec No. 2 (15 October 2007)
    by B Thomas, MF Beal
  • Recessive Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, Vol. 21, No. 7. (July 2006), pp. 885-893.
    by S Kubo, N Hattori, Y Mizuno
  • Parkinsonism genes: culprits and clues
    Journal of Neurochemistry, Vol. 99, No. 4. (November 2006), pp. 1062-1072.
    by Abeliovich, Asa, Flint Beal,
  • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/user/psique/tag/parkinsons

    Result page: 1 2 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.